PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer | The NEW ENGLAND JOURNAL Of MEDICINE

Authors: Andrea Cercek, M.D., Melissa Lumish, M.D. https://orcid.org/0000-0003-4173-5567, Jenna Sinopoli, N.P., Jill Weiss, B.A., Jinru Shia, M.D., MichelleLamendola-Essel, D.H.Sc., Imane H. El Dika, M.D., and Luis A. Diaz, Jr., M.D.

BACKGROUND

Neoadjuvant chemotherapy and radiation followed by surgical resection of the rectum is a standard treatment for locally advanced rectal cancer. A subset of rectal cancer is caused by a deficiency in mismatch repair. Because mismatch repair–deficient colorectal cancer is responsive to programmed death 1 (PD-1) blockade in the context of metastatic disease, it was hypothesized that checkpoint blockade could be effective in patients with mismatch repair–deficient, locally advanced rectal cancer.

METHODS

We initiated a prospective phase 2 study in which single-agent dostarlimab, an anti–PD-1 monoclonal antibody, was administered every 3 weeks for 6 months in patients with mismatch repair–deficient stage II or III rectal adenocarcinoma. This treatment was to be followed by standard chemoradiotherapy and surgery. Patients who had a clinical complete response after completion of dostarlimab therapy would proceed without chemoradiotherapy and surgery. The primary end points are sustained clinical complete response 12 months after completion of dostarlimab therapy or pathological complete response after completion of dostarlimab therapy with or without chemoradiotherapy and overall response to neoadjuvant dostarlimab therapy with or without chemoradiotherapy.
PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer

RESULTS

A total of 12 patients have completed treatment with dostarlimab and have undergone at least 6 months of follow-up. All 12 patients (100%; 95% confidence interval, 74 to 100) had a clinical complete response, with no evidence of tumor on magnetic resonance imaging, 18F-fluorodeoxyglucose–positron-emission tomography, endoscopic evaluation, digital rectal examination, or biopsy. At the time of this report, no patients had received chemoradiotherapy or undergone surgery, and no cases of progression or recurrence had been reported during follow-up (range, 6 to 25 months). No adverse events of grade 3 or higher have been reported.

CONCLUSIONS

Mismatch repair–deficient, locally advanced rectal cancer was highly sensitive to single-agent PD-1 blockade. Longer follow-up is needed to assess the duration of response. (Funded by the Simon and Eve Colin Foundation and others; ClinicalTrials.gov number, NCT04165772.)
Locally advanced rectal cancer is typically managed with multimodal therapy, including chemotherapy, radiation, and surgery. Current evidence supports a strategy involving the use of neoadjuvant therapy, in which induction chemotherapy with a fluoropyrimidine in combination with oxaliplatin is followed by chemoradiotherapy and then surgery.1-3 This approach results in a pathological complete response in up to a quarter of patients, but it is associated with marked complications and toxic effects — including bowel, urinary, and sexual dysfunction; infertility; and altered quality of life — in a substantial proportion of patients.4-6 In patients undergoing surgery, resection of the rectum is life-altering and often warrants a permanent diverting colostomy.6,7 Owing to the complications of surgery and the high frequency of pathological complete response, interest in organ-sparing nonoperative management is increasing. The use of clinical complete response that is achieved with neoadjuvant treatment as a surrogate for pathological complete response provides patients with a nonoperative option that results in a survival benefit that is similar to that in patients undergoing surgical resection.8-11
Approximately 5 to 10% of rectal adenocarcinomas are mismatch-repair deficient, and these tumors have been shown to respond poorly to standard chemotherapy regimens, including neoadjuvant chemotherapy in locally advanced rectal cancer.12-14 Immune checkpoint blockade alone has been shown to be highly effective as first-line treatment for patients with mismatch repair–deficient metastatic colorectal cancer, as well as for patients with treatment-refractory disease, with objective response rates of 33 to 55%, clinically significant durability of response, and prolonged overall survival.15-17
On the basis of the benefits seen in the context of metastatic disease, we hypothesized that single-agent programmed death 1 (PD-1) blockade alone might be beneficial in mismatch repair–deficient, locally advanced rectal cancer. To test this hypothesis, we initiated a phase 2 study to investigate the overall response and frequency of sustained clinical complete response to neoadjuvant treatment with dostarlimab, a PD-1 inhibitor, in this patient population.

Skip The Scoop | Seek Understanding

Bannon’s War Room | Morning Edition Hour 2 | Recorded June 30, 2021 | Video: 48 Minutes 44 Seconds

Show Me

U.K.’s Data Spying After Snowden Violated Privacy Rights

Show Me

Tucker Carlson Accuses Biden Administration’s NSA Of Spying On Him

Show Me

Election 2020 Fraud, The Big Lie? Think Again |The Real Big Lie Is The Reason Edward Snowden Became A Whistleblower: NSA Spying On Americans | Video: 4 Minutes 4 Seconds

Show Me

Flashback: March 2014 – Snowden Vindicated | Harvard Civil Rights

Show Me

NSA Denies Spying on Fox’s Tucker Carlson

Show Me

Myocarditis ‘Higher Than Expected’ Among Male Military Members After 2nd mRNA COVID-19 Vaccine Dose: Study

Show Me

Bannon’s War Room | Evening Edition | Recorded June 30, 2021 | Video: 48 Minutes 58 Seconds

Show Me

Q&A: Space Force Officer Punished for Opposing Marxism; Portland On Brink of Gang War | Video: 1 Hour 11 Minutes 34 Seconds

Show Me

Bannon’s War Room | Morning Edition Hour 1 | Recorded June 29, 2021 | Video: 48 Minutes 19 Seconds

Show Me

Bannon’s War Room | Morning Edition Hour 2 | Recorded June 29, 2021 | Video: 48 Minutes 19 Seconds

Show Me

Bannon’s War Room | Evening Edition | Recorded June 29, 2021 | Video: 48 Minutes 58 Seconds

Show Me

Spacecraft buzzes Jupiter’s mega moon, 1st close-up in years

Show Me

Alien contact could ‘end life on Earth,’ scientists warn

Show Me

Internet tags NASA’s new diversity program as ‘critical space theory’

Show Me

NASA Sends Dozens Of Squid Into Space To Understand Spaceflight’s Impact On Humans

Show Me

NASA’s Perseverance Rover Is Looking for Life on Mars

Show Me

U.S. has no explanation for unidentified objects and stops short of ruling out aliens

Show Me

Astronauts Complete Solar Panel Work in 3rd Spacewalk

Show Me

Chinese Space Station a Looming Threat to US, Experts Say

Show Me

Venus doesn’t have enough water in its clouds to sustain life

Show Me

Amelia Earhart – First Woman To Fly Alone Mini Biography | Video: 3 Minutes 20 Seconds

Show Me

Amelia Earhart: Queen Of The Air | Full Documentary | Video: 43 Minutes 11 Seconds

Show Me

Long-lost letter from Amelia Earhart’s captain detailing their final trip in 1937 is found

Show Me

Senior NASA Scientist Gets Just 30 Days Prison for Lying to FBI About CCP Collaboration.

Show Me

This Is Not About Ethical Violations, It’s About Removing President Trump’s Legal Representation | “Giuliani on Suspension of His Law License: ‘America Is Not America Any Longer’”

Show Me

Dr Fauci ‘lied’ to Congress by saying he didn’t know why Trump cancelled Wuhan lab grant

Show Me

Exclusive Summary: Covid-19 Vaccine Concerns

Show Me

Greece: Raped by Afghan, Pregnant Woman Pleaded for Help But Three Pakistanis Passing by Raped Her Too

Show Me

Woman loses it over biological male in day spa w/children: ‘I see a d*ck. That let’s me know he’s a man!’

Show Me

27 Shot Friday into Saturday Night Across Mayor Lori Lightfoot’s Chicago

Show Me

Suspect Who Shot Florida Police Officer in the Head Is Captured at Black Nationalist Camp near Atlanta

Show Me

Hospital Employee Faces Termination For Refusing To Submit ‘COVID Vaccine-Tracking’ Survey’

Show Me

YouTube Blocks Videos Exposing China’s Slow-Motion Genocide in Xinjiang

Show Me

This Is Why The Politicized Justice Department Is Suing Georgia & Threatening Arizona & Other States Reviewing The 2020 Election | Who Really Won The Presidency? | Video: 2 Minutes 53 Seconds

Show Me

J&J Agrees To Pay $230 Million To Settle New York Opioid Claim

Show Me

Full Speech: President Donald J. Trump Rally in Wellington, OH 6/26/21 | Video: 1 Hour 41 Minutes 16 Seconds

Show Me

Americans Are Starting To Wonder If Joe Biden Isn’t Actually Reverend Kane From The Movie Poltergeist | Video: 1 Minute 20 Seconds

Show Me

Arizona Senate Prepared For Action After Audit | Video: 2 Minutes 2 Seconds

Show Me

Bannon’s War Room | Morning Edition Hour 1 | Recorded June 28, 2021 | Video: 48 Minutes 39 Seconds

Show Me